Qiagen NV (NYSE:QGEN)
$ 46.01 -0.15 (-0.32%) Market Cap: 10.26 Bil Enterprise Value: 10.70 Bil PE Ratio: 113.42 PB Ratio: 2.91 GF Score: 87/100

Qiagen NV at Evercore ISI HealthCONx Virtual Conference Transcript

Nov 30, 2021 / 03:05PM GMT
Release Date Price: $56.84 (-0.88%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD

Okay. Thanks, everyone, for joining us this morning. I'm Vijay Kumar. I cover Life Science Tools and MedTech at Evercore. Pleasure to have with us at QIAGEN. We have with us Roland Sackers, the CFO. I think I might have John Gilardi as well on. There he is. I could see John waving out there.

It's always -- QIAGEN has been near and dear, it was for a variety of reasons over the years. It's -- unfortunately, we couldn't be part of the story for the last couple of years, but it's certainly been exciting for you guys.

Questions & Answers

Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD

From a far, Roland, when I think about the story, what the debate was 3 years ago versus now, it's changed. So I do want to dive in some of these things. But before I ask on the fundamentals, what's changed, maybe perhaps a lot of questions, can diagnostic companies detect a new Omicron variant? So maybe talk about whether your test

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot